CGEM compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

CGEMCullinan Therapeutics, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

CGEMCullinan Therapeutics, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only CGEM 7

—Chongqing Genrix Biopharmaceuticalunlistedsupplier

—Harbour BioMed USunlistedsupplier

—Taiho Pharmaceuticalunlistedsupplier

—Deutsches Krebsforschungszentrumunlistedsupplier

3 more · CGEM chain ›

Shared 0

No shared counterparties.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

8 more · AMGN chain ›

CGEMCullinan Therapeutics, Inc.

11.47▲+6.20%

Mkt cap$695.0MRevenue—Revenue—

AMGNAmgen Inc

459.64▼−0.14%

Regular sessionNov 6 '26

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

Compare

Regular sessionNov 6 '26

CGEMCullinan Therapeutics, Inc.

AMGNAmgen Inc

11.47▲+6.20%

Price

459.64▼−0.14%

$695.0M

Mkt cap

$249.0B

—

Revenue

$10.4BQ3 FY26

—

Revenue

$36.8BFY25

CGEM11.47▲+6.20%vsAMGN459.64▼−0.14%Regular sessionNov 6 '26